Real-time · AI · Cross-signal
Predictive Oncology just moved. Here's exactly what to do next.
Who to reach, what to say, and why now — on Predictive Oncology, plus every contract, funding round, and exec hire that follows. Verified, ICP-ranked contacts on demand (email + mobile).
Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.
Predictive Oncology Partners with Tecan Group Ltd. for High-Throughput Drug Screening Expansion
Feb 10, 2025•over 1 year ago
Contract Type
partnership
Description
Predictive Oncology Inc. announced a partnership with Switzerland-based Tecan, Ltd. to expand high-throughput drug screening to include human tumor spheroids using automated imaging and 3D analysis. This collaboration aims to utilize Predictive Oncology’s vast biobank of cryopreserved live cell tumor specimens for the production and testing of primary patient tumor spheroids.
Related People
Suggested for you
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months